enVVeno Medical Corporation
Other OTCTotal Valuation
enVVeno Medical Corporation carries a market capitalization of 141,513.00, placing it among publicly traded companies globally. Its enterprise value stands at -27.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 141,513.00 |
| Enterprise Value | -27.51M |
Share Statistics
enVVeno Medical Corporation currently has 656,000.00 shares outstanding.
| Shares Outstanding | 656,000.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
enVVeno Medical Corporation maintains a current ratio of 13.58, meaning it holds 13.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 13.58 |
| Quick Ratio | 13.30 |
| Debt / Equity | 2.58 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -52.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
enVVeno Medical Corporation's stock has declined approximately -97.66667% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.66667% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.20 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -20.41M, while operating income came in at -20.90M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -20.90M |
| Pretax Income | -19.47M |
| Net Income | -19.47M |
| EBITDA | -20.41M |
| EBIT | -20.90M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
enVVeno Medical Corporation holds 28.21M in cash and equivalents against 700,000.00 in total debt, resulting in a net debt position of -3.06M. Total book value stands at -171.33M, with working capital of 26.70M providing operational flexibility.
| Cash & Cash Equivalents | 28.21M |
| Total Debt | 700,000.00 |
| Net Debt | -3.06M |
| Equity (Book Value) | -171.33M |
| Book Value Per Share | N/A |
| Working Capital | 26.70M |
Cash Flow
enVVeno Medical Corporation produced -15.57M in operating cash flow over the past twelve months.
| Operating Cash Flow | -15.57M |
| Capital Expenditures | -5,000.00 |
| Free Cash Flow | -15.57M |
| FCF Per Share | N/A |
Scores
enVVeno Medical Corporation posts an Altman Z-Score of -9.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -9.36 |